The primary limitation of our study is the fact that the literature search did not include all possible mutations implied in FGR (e.g., PAI-1 mutation, for which it is not clearly defined whether the connection between the thrombophilia diagnosis and fetal growth restriction is sustained). The gene discussed is SERPINE1; the disease is Rare hereditary thrombophilia.